Biomx Financials
| PHGE Stock | USD 0.73 0.02 2.82% |
Biomx |
Please note, the presentation of Biomx's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomx's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biomx's management manipulating its earnings.
Biomx Stock Summary
Biomx competes with ZyVersa Therapeutics, Immix Biopharma, and Sonnet Biotherapeutics. BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel. Biomx operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 103 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NYSE MKT Exchange |
| ISIN | US09090D1037 |
| CUSIP | 09090D103 15957A108 09090D301 |
| Location | New York; U.S.A |
| Business Address | 22 Einstein Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.biomx.com |
| Phone | 972 7 2394 2377 |
| Currency | USD - US Dollar |
Biomx Key Financial Ratios
Biomx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biomx's current stock value. Our valuation model uses many indicators to compare Biomx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomx competition to find correlations between indicators driving Biomx's intrinsic value. More Info.Biomx Inc is regarded fifth in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Biomx by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Biomx Inc Systematic Risk
Biomx's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biomx volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Biomx Inc correlated with the market. If Beta is less than 0 Biomx generally moves in the opposite direction as compared to the market. If Biomx Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biomx Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biomx is generally in the same direction as the market. If Beta > 1 Biomx moves generally in the same direction as, but more than the movement of the benchmark.
About Biomx Financials
What exactly are Biomx Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Biomx's income statement, its balance sheet, and the statement of cash flows. Potential Biomx investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Biomx investors may use each financial statement separately, they are all related. The changes in Biomx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biomx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Biomx February 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biomx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biomx Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomx Inc based on widely used predictive technical indicators. In general, we focus on analyzing Biomx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomx's daily price indicators and compare them against related drivers.
| Downside Deviation | 7.06 | |||
| Information Ratio | 0.0219 | |||
| Maximum Drawdown | 32.03 | |||
| Value At Risk | (11.29) | |||
| Potential Upside | 10.2 |
Complementary Tools for Biomx Stock analysis
When running Biomx's price analysis, check to measure Biomx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomx is operating at the current time. Most of Biomx's value examination focuses on studying past and present price action to predict the probability of Biomx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomx's price. Additionally, you may evaluate how the addition of Biomx to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |